Allarity Therapeutics, Inc. Common Stock

ALLRNASDAQ • USD
ThemeHealthcare - Oncology›Targeted Therapy & Precision Oncology
0.92 USD
↗ 0.01 (0.65%)🟢LIVE (AS OF 01:11 PM EDT)
🟢Market: OPEN

Shares of Allarity Therapeutics, Inc. Common Stock (ALLR) are trading at $0.92. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation front, ALLR trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.

Technical & fundamental data as of Oct 26, 2026.

Open?$0.93
High?$0.96
Low?$0.90
Prev. Close?$0.92
Volume?96.8K
Avg. Volume?130.2K
VWAP?$0.92
Rel. Volume?0.74x
Bid / Ask
Bid?$0.77 × 100
Ask?$1.07 × 100
Spread?$0.30
Midpoint?$0.92
Valuation & Ratios
Market Cap?14.6M
Shares Out?15.9M
Float?15.8M
Float %?99.8%
P/E Ratio?N/A
P/B Ratio?4.14
EPS?-$0.78
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States. It is focused on the clinical development of its lead program: Stenoparib, which is being co-developed with a drug specific DRP companion diagnostic.
Themes
Healthcare - Oncology›Targeted Therapy & Precision OncologyHealthcare - Genomics & Precision Medicine›Precision Medicine Platforms
Employees
8
Market Cap
13.8M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.allarity.com
Listed
2021-12-21
Address
24 SCHOOL ST., 2ND FLOOR
BOSTON, MA 02108
Phone: 401-426-4664
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
23
Short Sent.?
60
Piotroski F-Score?0/9Weak
Altman Z-Score?-6.62Distress
Confidence?51%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?1.06%Low
Short Interest?168.0K
Days to Cover?1.4
Free Float15.8M
Avg Daily Volume121.1K
Settlement Date2026-10-15
Financial Health
Current Ratio?1.11Adequate
Quick Ratio?1.11Adequate
Cash Ratio?0.59Adequate
Debt/Equity?6.30High
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A▾
P/B?
Peers
100
S&P
43
4.14FAIR▾
P/S?
Peers
100
S&P
3
42.43HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-1.8CHEAP▾
EV/Sales?
Peers
100
S&P
3
57.80HIGH▾
Returns & Efficiency
ROE?
S&P
3
-348.8%WEAK▾
ROA?
S&P
3
-38.4%WEAK▾
Cash Flow & Enterprise
FCF?$-13782000
Enterprise Value?$19.9M
Fundamentals ratios updated end of day
MarketsMoversWatchlist